Bio-Techne (TECH) Competitors

Bio-Techne (NASDAQ:TECH) and Bruker (NASDAQ:BRKR) are both mid-cap life sciences tools & services companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation.

Is TECH or BRKR more profitable?

Bio-Techne has a net margin of 6.02% compared to Bruker's net margin of 2.31%. Bruker's return on equity of 17.89% beat Bio-Techne's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bio-Techne	6.02%	13.43%	10.32%
Bruker	2.31%	17.89%	5.38%

Does the media refer more to TECH or BRKR?

In the previous week, Bruker had 9 more articles in the media than Bio-Techne. MarketBeat recorded 26 mentions for Bruker and 17 mentions for Bio-Techne. Bio-Techne's average media sentiment score of 1.51 beat Bruker's score of 0.67 indicating that Bio-Techne is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bio-Techne	14 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Bruker	14 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Positive

Do analysts recommend TECH or BRKR?

Bio-Techne currently has a consensus target price of $70.42, indicating a potential upside of 33.06%. Bruker has a consensus target price of $51.30, indicating a potential upside of 72.21%. Given Bruker's higher probable upside, analysts plainly believe Bruker is more favorable than Bio-Techne.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Techne	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.75
Bruker	0 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.45

Is TECH or BRKR a better dividend stock?

Bio-Techne pays an annual dividend of $0.32 per share and has a dividend yield of 0.6%. Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.7%. Bio-Techne pays out 69.6% of its earnings in the form of a dividend. Bruker pays out 38.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Bruker is clearly the better dividend stock, given its higher yield and lower payout ratio.

Which has more risk and volatility, TECH or BRKR?

Bio-Techne has a beta of 1.47, indicating that its stock price is 47% more volatile than the S&P 500. Comparatively, Bruker has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500.

Which has preferable valuation and earnings, TECH or BRKR?

Bruker has higher revenue and earnings than Bio-Techne. Bruker is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Techne	$1.22B	6.80	$73.40M	$0.46	115.04
Bruker	$3.37B	1.34	$113.10M	$0.52	57.29

Do insiders & institutionals believe in TECH or BRKR?

99.0% of Bio-Techne shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 3.9% of Bio-Techne shares are owned by insiders. Comparatively, 27.3% of Bruker shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Bio-Techne beats Bruker on 10 of the 19 factors compared between the two stocks.